VENLAFAXINE HCL ER (venlafaxine HCl)
ANTIDEPRESSANTS · MAJOR DEPRESSIVE DISORDER ·+1
WESTMINSTER PHA
Drug class
Antidepressant Serotonin-Norepinephrine Reuptake Inh.(SNRIs)
Antidepressant serotonin-norepinephrine reuptake inhibitors (SNRIs) constitute a class of psychotropic medications primarily designed to treat mood and chronic pain disorders. Read more about Antidepressant Serotonin-Norepinephrine Reuptake Inh.(SNRIs)
127 drugs in this class 71 manufacturers
Drugs in Antidepressant Serotonin-Norepinephrine Reuptake Inh.(SNRIs)
MILNACIPRAN HCL
ANTIDEPRESSANTS · FIBROMYALGIA
BRECKENRIDGE
MILNACIPRAN HCL
ANTIDEPRESSANTS · FIBROMYALGIA
CAMBER PHARMACE
MILNACIPRAN HCL
ANTIDEPRESSANTS · FIBROMYALGIA
GLENMARK PHARMA
VENLAFAXINE HCL ER (venlafaxine HCl)
ANTIDEPRESSANTS · MAJOR DEPRESSIVE DISORDER ·+4
NORTHSTAR RX LL
DULOXETINE HCL
ANTIDEPRESSANTS · MAJOR DEPRESSIVE DISORDER ·+1
ALMATICA PHARMA
VENLAFAXINE HCL ER (venlafaxine HCl)
ANTIDEPRESSANTS · MAJOR DEPRESSIVE DISORDER ·+4
BLU PHARMACEUTI
DULOXETINE HCL
ANTIDEPRESSANTS · MAJOR DEPRESSIVE DISORDER ·+5
HAWAII REPACK,
DULOXETINE HCL
ANTIDEPRESSANTS · MAJOR DEPRESSIVE DISORDER ·+5
ALEMBIC PHARMAC
Filter & compare in the drug finder →
Opens the drug finder with Antidepressant Serotonin-Norepinephrine Reuptake Inh.(SNRIs) preselected. Add indication or manufacturer filters there.
Antidepressant serotonin-norepinephrine reuptake inhibitors (SNRIs) constitute a class of psychotropic medications primarily designed to treat mood and chronic pain disorders.
They exert their therapeutic effect by inhibiting the presynaptic reuptake transporters for both serotonin and norepinephrine, thereby elevating the synaptic concentrations and neurotransmission of these monoamines in the central nervous system.
Clinically, members of this class are widely approved and indicated for major depressive disorder, generalized anxiety disorder, panic disorder, and social anxiety disorder.
Additionally, due to their descending pain pathway modulation, certain SNRIs are established therapies for chronic pain syndromes, including fibromyalgia, diabetic peripheral neuropathic pain, and chronic musculoskeletal pain.
-
mayoclinic.org
Antidepressant serotonin-norepinephrine reuptake inhibitors (SNRIs) constitute a class of psychotropic medications primarily designed to treat mood and chronic pain disorders Clinically, members of this class are widely approved and indicated for major depressive disorder, generalized anxiety disorder, panic disorder, and social anxiety disorder Additionally, due to their descending pain pathway modulation, certain SNRIs are established therapies for chronic pain syndromes, including fibromyalgi...
-
nih.gov
Antidepressant serotonin-norepinephrine reuptake inhibitors (SNRIs) constitute a class of psychotropic medications primarily designed to treat mood and chronic pain disorders They exert their therapeutic effect by inhibiting the presynaptic reuptake transporters for both serotonin and norepinephrine, thereby elevating the synaptic concentrations and neurotransmission of these monoamines in the central nervous system Additionally, due to their descending pain pathway modulation, certain SNRIs are...
-
nih.gov
Clinically, members of this class are widely approved and indicated for major depressive disorder, generalized anxiety disorder, panic disorder, and social anxiety disorder
Sign in to follow this class
Following a drug class requires a free Physicians Office Resource account.